Weighted Average Number of Shares Outstanding, Basic of NAVIDEA BIOPHARMACEUTICALS, INC. from 2015 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2015 to Q3 2023.
  • Navidea Biopharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2023 was 99.4M shares, a 223% increase year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 30.9M shares, a 5.31% increase from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 29.3M shares.
  • Navidea Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2018 was 171M shares, a 5.53% increase from 2017.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 99.4M +68.6M +223% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 48.2M +18M +59.4% 01 Apr 2023 30 Jun 2023 10-Q 11 Aug 2023
Q1 2023 32.7M +2.45M +8.1% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q4 2022 30.9M +1.56M +5.31% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2023
Q3 2022 30.7M +609K +2.02% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 30.3M +1.15M +3.95% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 30.2M +2.14M +7.63% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 29.3M 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2023
Q3 2021 30.1M 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 29.1M 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 28.1M 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q1 2019 10M +1.9M +23.5% 01 Jan 2019 31 Mar 2019 10-Q 09 May 2019
Q4 2018 171M +8.94M +5.53% 01 Oct 2018 31 Dec 2018 10-K 15 Mar 2019
Q3 2018 167M +4.85M +2.99% 01 Jul 2018 30 Sep 2018 10-Q 09 Nov 2018
Q2 2018 163M +806K +0.5% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2018
Q1 2018 8.11M -152M -94.9% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 162M +6.17M +3.97% 01 Oct 2017 31 Dec 2017 10-K 15 Mar 2019
Q3 2017 162M +6.53M +4.2% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 162M +6.53M +4.2% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018
Q1 2017 160M +5.07M +3.26% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 155M 01 Oct 2016 31 Dec 2016 10-K 15 Mar 2018
Q3 2016 155M 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 155M 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017
Q1 2016 155M 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017

NAVIDEA BIOPHARMACEUTICALS, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 30.9M +1.56M +5.31% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2023
2021 29.3M 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023
2018 171M +8.94M +5.53% 01 Jan 2018 31 Dec 2018 10-K 15 Mar 2019
2017 162M +6.17M +3.97% 01 Jan 2017 31 Dec 2017 10-K 15 Mar 2019
2016 155M +4.24M +2.81% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2018
2015 151M 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.